-
Quick review of 2022 Drug Review Annual Report
2023-11-14
In 2022, the NMPA reviewed and recommended the approval of 21 innovative drugs, including 3 first-in-class drugs.
-
NMPA becomes the applicant for PIC/S
2023-11-09
In late September 2023, the National Medical Products Administration (NMPA) submitted the formal application to the Pharmaceutical Inspection Co-operation Scheme (PIC/S). On Nov 8, 2023, PIC/S sent a letter to NMPA confirming the applicant status.
-
China issues evaluation standard for childcare institutions
2023-11-08
China's National Health Commission has released an evaluation standard for the quality of childcare institutions, setting criteria for running institutions providing childcare services for children under three.
-
China achieves interconnectivity of citizens' health information
2023-11-08
China has built a platform of citizens' health information that connects relevant networks at national, provincial, city and county levels, a health official said Tuesday.
-
China sees continuous improvement in health service capacity
2023-11-03
The health service capacity of medical institutions in China has seen significant improvement in 2023, Chinese health officials said Wednesday.
-
Robot-Assisted Fracture Reduction System for Pelvic Fracture Approved for Marketing
2023-12-11
Recently, the innovative product Robot-Assisted Fracture Reduction System for Pelvic Fracture of Beijing Rossum Robot Technology Co., Ltd. is approved by China NMPA.
